NorthShore University Health System ...

Dr. Mark Ricciardi

Claim this profile

Northshore University HealthSystem

Studies Mitral Regurgitation
Studies Mitral Valve Regurgitation
6 reported clinical trials
9 drugs studied

Affiliated Hospitals

Image of trial facility.

Northshore University HealthSystem

Image of trial facility.

NorthShore University

Clinical Trials Mark Ricciardi is currently running

Image of trial facility.

AccuCinch System

for Heart Failure

This trial is testing a new device called the AccuCinch Ventricular Restoration System in patients with a specific type of heart failure. The device helps the heart pump blood more effectively by supporting and reshaping its lower chamber. The study aims to see if this device, combined with standard medical treatment, is safe and effective. The CorCap Cardiac Support Device (CSD) is a predecessor that has shown safety and effectiveness in improving left ventricular structure and function in heart failure patients.

Recruiting

1 award

N/A

9 criteria

Image of trial facility.

Transseptal ViMAC

for Mitral Valve Disease

A prospective multicenter study enrolling high surgical risk patients with severe mitral annular calcification (MAC) and symptomatic mitral valve dysfunction (severe stenosis, ≥ moderate to severe regurgitation, or mixed ≥ moderate stenosis and ≥ regurgitation). There are 2 Arms in this study: 1) "Transseptal (TS) Valve-in-MAC" (ViMAC) Arm, and 2) Natural History of Disease Registry (NHDR) for patients treated with medical treatment only (which includes patients who meet inclusion criteria but can't be treated with transeptal ViMAC due to the presence of anatomical exclusion criteria or other exclusion criteria) and have not had other procedures that may impact outcomes (i.e., alcohol septal ablation or radiofrequency ablation). The study also includes a Registry of Permanently Unassigned" for subjects who undergo preemptive septal ablation procedures (alcohol or radiofrequency) in anticipation of continuing onto ViMAC arm, but are not accepted in the ViMAC Study arm or the patient chooses not to undergo ViMAC procedure.

Recruiting

1 award

N/A

2 criteria

More about Mark Ricciardi

Clinical Trial Related

6 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Mark Ricciardi has experience with

  • TriClip Device
  • Transseptal ViMAC
  • MitraClip G4 System
  • AccuCinch Ventricular Restoration System
  • Guideline-Directed Medical Therapy
  • Impella®-Supported PCI

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Mark Ricciardi specialize in?

Is Mark Ricciardi currently recruiting for clinical trials?

Are there any treatments that Mark Ricciardi has studied deeply?

What is the best way to schedule an appointment with Mark Ricciardi?

What is the office address of Mark Ricciardi?

Is there any support for travel costs?